January 27, 2023
CBD is an established product that is paving the way for other hemp-derived cannabinoids. However, regulation remains a big if for the category.
January 26, 2023
The U.S. Food and Drug Administration has reached the conclusion that “a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”
January 24, 2023
FDA warning letters in 2022 remind cardiovascular product companies about what they should and shouldn’t do in 2023.
FermentIQ is designed to improve the sensory, functional, and nutritional attributes of plant protein, the company says.
January 20, 2023
Astrion is a combination of Centella asiatica and Astragalus membranaceus that the company says has been clinically shown to support skin health.
January 18, 2023
David Murray, the director of the Office of Disease Prevention at the National Institutes of Health, is currently serving as the acting director of the Office of Dietary Supplements (ODS) until a new, permanent ODS director is selected.
January 17, 2023
Nutritional Outlook’s Editorial Advisory Board shares its predictions and tips for success in 2023.
January 10, 2023
FDA’s final guidance outlines how importers should comply with FSVP requirements, including those for importers of dietary supplements.
January 03, 2023
New York Governor Kathy Hochul has vetoed Assembly Bill 431-C, which would restrict minors from purchasing weight management and muscle building dietary supplements without a prescription.
The Council for Responsible Nutrition has issued a statement expressing disappointment at the exclusion of a mandatory product listing provision from the recently passed omnibus spending package. However, the association sees its passage as inevitable.